Kim Kelderman Bio Techne Corp (TECH) insider trading activity

Kim Kelderman is Chief Executive Officer of BIO-TECHNE Corp. Currently has a direct ownership of 46,730 shares of TECH, which is worth approximately $2.36 Million. The most recent transaction as insider was on Jul 22, 2025, when has been sold 43,649 shares (Common Stock) at a price of $53.12 per share, resulting in proceeds of $2,318,634. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.7K

19.81% 3M change

16.99% 12M change

Total Value Held $2.36 Million

Kim Kelderman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 22 2025	SELL Payment of exercise price or tax liability	$2,318,634 $53.12 p/Share	43,649 Reduced 48.3%	46,730 Common Stock
Jul 22 2025	BUY Exercise of conversion of derivative security	$2,135,642 $44.33 p/Share	48,176 Added 34.77%	90,379 Common Stock
Jul 15 2025	SELL Payment of exercise price or tax liability	$1,693,414 $51.42 p/Share	32,933 Reduced 43.83%	42,203 Common Stock
Jul 15 2025	BUY Exercise of conversion of derivative security	$1,601,731 $44.33 p/Share	36,132 Added 32.47%	75,136 Common Stock
Jan 27 2025	SELL Open market or private sale	$1,038,817 $77.57 p/Share	13,392 Reduced 25.56%	39,004 Common Stock
Jan 27 2025	BUY Exercise of conversion of derivative security	$504,878 $37.7 p/Share	13,392 Added 20.36%	52,396 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$183,003 $75.31 p/Share	2,430 Reduced 5.86%	39,004 Common Stock
Aug 29 2024	BUY Exercise of conversion of derivative security	$99,919 $66.97 p/Share	1,492 Added 3.48%	41,434 Common Stock
Jul 31 2024	SELL Payment of exercise price or tax liability	$776,993 $81.97 p/Share	9,479 Reduced 19.18%	39,942 Common Stock
Jul 31 2024	BUY Exercise of conversion of derivative security	$527,800 $37.7 p/Share	14,000 Added 22.07%	49,421 Common Stock
Nov 01 2023	BUY Grant, award, or other acquisition	-	14,196 Added 28.61%	35,421 Common Stock
Aug 24 2023	BUY Exercise of conversion of derivative security	$99,960 $47.6 p/Share	2,100 Added 9.0%	21,225 Common Stock
Aug 05 2023	SELL Payment of exercise price or tax liability	$340,101 $82.17 p/Share	4,139 Reduced 17.79%	19,125 Common Stock
Aug 05 2023	BUY Exercise of conversion of derivative security	-	8,060 Added 25.73%	23,264 Common Stock
Aug 23 2022	BUY Exercise of conversion of derivative security	$99,967 $150.78 p/Share	663 Added 14.85%	3,801 Common Stock
Aug 07 2022	SELL Payment of exercise price or tax liability	$464,926 $382.97 p/Share	1,214 Reduced 27.9%	3,138 Common Stock
Aug 07 2022	BUY Exercise of conversion of derivative security	-	2,363 Added 35.19%	4,352 Common Stock
Feb 08 2022	BUY Exercise of conversion of derivative security	$299,901 $150.78 p/Share	1,989 Added 50.0%	1,989 Common Stock
Nov 19 2021	SELL Open market or private sale	$252,385 $504.77 p/Share	500 Reduced 100.0%	0 Common Stock
Nov 19 2021	BUY Exercise of conversion of derivative security	$75,390 $150.78 p/Share	500 Added 50.0%	500 Common Stock
Sep 22 2021	SELL Open market or private sale	$434,871 $529.04 p/Share	822 Reduced 100.0%	0 Common Stock
Aug 08 2021	SELL Payment of exercise price or tax liability	$418,702 $481.82 p/Share	869 Reduced 51.39%	822 Common Stock
Aug 08 2021	BUY Exercise of conversion of derivative security	-	1,691 Added 50.0%	1,691 Common Stock
Jun 09 2021	SELL Open market or private sale	$351,163 $433.0 p/Share	811 Reduced 100.0%	0 Common Stock
May 25 2021	SELL Open market or private sale	$358,280 $424.0 p/Share	845 Reduced 51.03%	811 Common Stock

Kim Kelderman

Chief Executive Officer

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH

Account